由产科出血导致的严重孕产妇发病率:马里兰州,2020-2022年。

IF 3.8 2区 医学 Q1 OBSTETRICS & GYNECOLOGY American Journal of Obstetrics & Gynecology Mfm Pub Date : 2025-02-01 DOI:10.1016/j.ajogmf.2024.101589
Carrie Wolfson PHD , Jessica Tsipe Angelson MS, CNM , Robert Atlas MD , Irina Burd MD, PHD , Pamela Chin MS, PA-C , Cathy Downey BSN, RN , Jenifer Fahey CNM, PhD , Susan Hoffman BSN , Clark T. Johnson MD , Monica B. Jones MD , Kimberly Jones-Beatty DNP, MSN, CNM , Jennifer Kasirsky MD , Daniel Kirsch MD , Ichchha Madan MD , Donna Neale MD , Joanne Olaku MSN , Michelle Phillips BSN , Amber Richter MSN , Jeanne Sheffield MD , Danielle Silldorff MS , Andreea Creanga MD, PHD
{"title":"由产科出血导致的严重孕产妇发病率:马里兰州,2020-2022年。","authors":"Carrie Wolfson PHD ,&nbsp;Jessica Tsipe Angelson MS, CNM ,&nbsp;Robert Atlas MD ,&nbsp;Irina Burd MD, PHD ,&nbsp;Pamela Chin MS, PA-C ,&nbsp;Cathy Downey BSN, RN ,&nbsp;Jenifer Fahey CNM, PhD ,&nbsp;Susan Hoffman BSN ,&nbsp;Clark T. Johnson MD ,&nbsp;Monica B. Jones MD ,&nbsp;Kimberly Jones-Beatty DNP, MSN, CNM ,&nbsp;Jennifer Kasirsky MD ,&nbsp;Daniel Kirsch MD ,&nbsp;Ichchha Madan MD ,&nbsp;Donna Neale MD ,&nbsp;Joanne Olaku MSN ,&nbsp;Michelle Phillips BSN ,&nbsp;Amber Richter MSN ,&nbsp;Jeanne Sheffield MD ,&nbsp;Danielle Silldorff MS ,&nbsp;Andreea Creanga MD, PHD","doi":"10.1016/j.ajogmf.2024.101589","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Obstetric hemorrhage is the leading cause of maternal mortality and severe maternal morbidity (SMM) in Maryland and nationally. Currently, through a quality collaborative, the state is implementing the Alliance for Innovation on Maternal Health (AIM) patient safety bundle on obstetric hemorrhage.</div></div><div><h3>Objective</h3><div>To describe SMM events contributed by obstetric hemorrhage and their preventability in Maryland.</div></div><div><h3>Study Design</h3><div>This cross-sectional study used data from hospital-based SMM surveillance and review program in Maryland. Hospital-based SMM criteria include admission to an intensive care unit and/or transfusion of 4 or more units of blood products (of any type) during pregnancy or within 42 days postpartum. A total of 193 obstetric hemorrhage events that met the surveillance definition were identified in hospitals participating in SMM surveillance since inception on August 1, 2020 until December 31, 2022. We compared patient and delivery characteristics, practices done well, and recommendations for care improvement among patients with severe obstetric hemorrhage deemed preventable and non-preventable by hospital-based review committees. For obstetric hemorrhage events deemed preventable, we further identified factors that contributed to the SMM outcome at the provider, system, and patient levels.</div></div><div><h3>Results</h3><div>Uterine atony was the leading cause of obstetric hemorrhage events (37.8%), followed by uterine rupture, laceration and intra-abdominal bleeding (23.8%). Sixty-six (34.2%) obstetric hemorrhage events were preventable. Patients with preventable obstetric hemorrhage were significantly more likely to have an emergency than planned cesarean delivery and less likely to have a placental complication or &gt;1500 mL blood loss volume. Hospital-based review committees determined that 81.8%, 30.3%, and 22.7% of preventable events could have been prevented or made less severe through changes to provider, system, or patient factors, respectively. Recommendations following event reviews aligned with the Alliance for Innovation on Maternal Health Obstetric Hemorrhage Patient Safety Bundle, particularly regarding elements in the Recognition and Prevention and Response domains.</div></div><div><h3>Conclusion</h3><div>About one-third of SMM events contributed by obstetric hemorrhages were deemed preventable. Of AIM bundle elements, assessing hemorrhage risk on admission to labor and delivery, peripartum, and upon transition to postpartum care together with rapid, unit-standardized management of hemorrhage are likely to benefit more than half of patients with preventable SMM contributed by obstetric hemorrhage.</div></div>","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"7 2","pages":"Article 101589"},"PeriodicalIF":3.8000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Severe maternal morbidity contributed by obstetric hemorrhage: Maryland, 2020-2022\",\"authors\":\"Carrie Wolfson PHD ,&nbsp;Jessica Tsipe Angelson MS, CNM ,&nbsp;Robert Atlas MD ,&nbsp;Irina Burd MD, PHD ,&nbsp;Pamela Chin MS, PA-C ,&nbsp;Cathy Downey BSN, RN ,&nbsp;Jenifer Fahey CNM, PhD ,&nbsp;Susan Hoffman BSN ,&nbsp;Clark T. Johnson MD ,&nbsp;Monica B. Jones MD ,&nbsp;Kimberly Jones-Beatty DNP, MSN, CNM ,&nbsp;Jennifer Kasirsky MD ,&nbsp;Daniel Kirsch MD ,&nbsp;Ichchha Madan MD ,&nbsp;Donna Neale MD ,&nbsp;Joanne Olaku MSN ,&nbsp;Michelle Phillips BSN ,&nbsp;Amber Richter MSN ,&nbsp;Jeanne Sheffield MD ,&nbsp;Danielle Silldorff MS ,&nbsp;Andreea Creanga MD, PHD\",\"doi\":\"10.1016/j.ajogmf.2024.101589\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Obstetric hemorrhage is the leading cause of maternal mortality and severe maternal morbidity (SMM) in Maryland and nationally. Currently, through a quality collaborative, the state is implementing the Alliance for Innovation on Maternal Health (AIM) patient safety bundle on obstetric hemorrhage.</div></div><div><h3>Objective</h3><div>To describe SMM events contributed by obstetric hemorrhage and their preventability in Maryland.</div></div><div><h3>Study Design</h3><div>This cross-sectional study used data from hospital-based SMM surveillance and review program in Maryland. Hospital-based SMM criteria include admission to an intensive care unit and/or transfusion of 4 or more units of blood products (of any type) during pregnancy or within 42 days postpartum. A total of 193 obstetric hemorrhage events that met the surveillance definition were identified in hospitals participating in SMM surveillance since inception on August 1, 2020 until December 31, 2022. We compared patient and delivery characteristics, practices done well, and recommendations for care improvement among patients with severe obstetric hemorrhage deemed preventable and non-preventable by hospital-based review committees. For obstetric hemorrhage events deemed preventable, we further identified factors that contributed to the SMM outcome at the provider, system, and patient levels.</div></div><div><h3>Results</h3><div>Uterine atony was the leading cause of obstetric hemorrhage events (37.8%), followed by uterine rupture, laceration and intra-abdominal bleeding (23.8%). Sixty-six (34.2%) obstetric hemorrhage events were preventable. Patients with preventable obstetric hemorrhage were significantly more likely to have an emergency than planned cesarean delivery and less likely to have a placental complication or &gt;1500 mL blood loss volume. Hospital-based review committees determined that 81.8%, 30.3%, and 22.7% of preventable events could have been prevented or made less severe through changes to provider, system, or patient factors, respectively. Recommendations following event reviews aligned with the Alliance for Innovation on Maternal Health Obstetric Hemorrhage Patient Safety Bundle, particularly regarding elements in the Recognition and Prevention and Response domains.</div></div><div><h3>Conclusion</h3><div>About one-third of SMM events contributed by obstetric hemorrhages were deemed preventable. Of AIM bundle elements, assessing hemorrhage risk on admission to labor and delivery, peripartum, and upon transition to postpartum care together with rapid, unit-standardized management of hemorrhage are likely to benefit more than half of patients with preventable SMM contributed by obstetric hemorrhage.</div></div>\",\"PeriodicalId\":36186,\"journal\":{\"name\":\"American Journal of Obstetrics & Gynecology Mfm\",\"volume\":\"7 2\",\"pages\":\"Article 101589\"},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2025-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Obstetrics & Gynecology Mfm\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S258993332400315X\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Obstetrics & Gynecology Mfm","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S258993332400315X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:产科出血是马里兰州和全国孕产妇死亡和严重孕产妇发病率(SMM)的主要原因。目前,通过高质量的合作,国家正在实施产妇保健创新联盟(AIM)关于产科出血的病人安全捆绑包。目的:描述马里兰州产科出血导致的SMM事件及其可预防性。研究设计:这项横断面研究使用了马里兰州医院SMM监测和审查项目的数据。基于医院的SMM标准包括在怀孕期间或产后42天内入住重症监护病房和/或输血4个或更多单位的血液制品(任何类型)。自2020年8月1日至2022年12月31日,参与SMM监测的医院共确定了193例符合监测定义的产科出血事件。我们比较了医院审查委员会认为可预防和不可预防的严重产科出血患者的患者和分娩特征、良好的实践和护理改进建议。对于可预防的产科出血事件,我们进一步确定了在提供者、系统和患者水平上影响SMM结果的因素。结果:子宫张力失调是产科出血事件的主要原因(37.8%),其次是子宫破裂、撕裂伤和腹腔出血(23.8%)。66例(34.2%)产科出血事件是可以预防的。与计划剖宫产相比,可预防的产科出血患者发生急诊的可能性明显更高,发生胎盘并发症或失血量达1500毫升的可能性更低。以医院为基础的审查委员会确定,81.8%、30.3%和22.7%的可预防事件可以通过改变提供者、系统或患者因素来预防或减轻严重程度。事件审查后提出的建议与孕产妇保健产科出血患者安全一揽子创新联盟保持一致,特别是关于识别、预防和应对领域的要素。结论:由产科出血引起的SMM事件中约有三分之一是可以预防的。在AIM一揽子要素中,在分娩、围产期和产后护理过渡时评估出血风险,以及对出血进行快速、单位标准化的管理,可能使一半以上由产科出血引起的可预防的SMM患者受益。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Severe maternal morbidity contributed by obstetric hemorrhage: Maryland, 2020-2022

Background

Obstetric hemorrhage is the leading cause of maternal mortality and severe maternal morbidity (SMM) in Maryland and nationally. Currently, through a quality collaborative, the state is implementing the Alliance for Innovation on Maternal Health (AIM) patient safety bundle on obstetric hemorrhage.

Objective

To describe SMM events contributed by obstetric hemorrhage and their preventability in Maryland.

Study Design

This cross-sectional study used data from hospital-based SMM surveillance and review program in Maryland. Hospital-based SMM criteria include admission to an intensive care unit and/or transfusion of 4 or more units of blood products (of any type) during pregnancy or within 42 days postpartum. A total of 193 obstetric hemorrhage events that met the surveillance definition were identified in hospitals participating in SMM surveillance since inception on August 1, 2020 until December 31, 2022. We compared patient and delivery characteristics, practices done well, and recommendations for care improvement among patients with severe obstetric hemorrhage deemed preventable and non-preventable by hospital-based review committees. For obstetric hemorrhage events deemed preventable, we further identified factors that contributed to the SMM outcome at the provider, system, and patient levels.

Results

Uterine atony was the leading cause of obstetric hemorrhage events (37.8%), followed by uterine rupture, laceration and intra-abdominal bleeding (23.8%). Sixty-six (34.2%) obstetric hemorrhage events were preventable. Patients with preventable obstetric hemorrhage were significantly more likely to have an emergency than planned cesarean delivery and less likely to have a placental complication or >1500 mL blood loss volume. Hospital-based review committees determined that 81.8%, 30.3%, and 22.7% of preventable events could have been prevented or made less severe through changes to provider, system, or patient factors, respectively. Recommendations following event reviews aligned with the Alliance for Innovation on Maternal Health Obstetric Hemorrhage Patient Safety Bundle, particularly regarding elements in the Recognition and Prevention and Response domains.

Conclusion

About one-third of SMM events contributed by obstetric hemorrhages were deemed preventable. Of AIM bundle elements, assessing hemorrhage risk on admission to labor and delivery, peripartum, and upon transition to postpartum care together with rapid, unit-standardized management of hemorrhage are likely to benefit more than half of patients with preventable SMM contributed by obstetric hemorrhage.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
7.40
自引率
3.20%
发文量
254
审稿时长
40 days
期刊介绍: The American Journal of Obstetrics and Gynecology (AJOG) is a highly esteemed publication with two companion titles. One of these is the American Journal of Obstetrics and Gynecology Maternal-Fetal Medicine (AJOG MFM), which is dedicated to the latest research in the field of maternal-fetal medicine, specifically concerning high-risk pregnancies. The journal encompasses a wide range of topics, including: Maternal Complications: It addresses significant studies that have the potential to change clinical practice regarding complications faced by pregnant women. Fetal Complications: The journal covers prenatal diagnosis, ultrasound, and genetic issues related to the fetus, providing insights into the management and care of fetal health. Prenatal Care: It discusses the best practices in prenatal care to ensure the health and well-being of both the mother and the unborn child. Intrapartum Care: It provides guidance on the care provided during the childbirth process, which is critical for the safety of both mother and baby. Postpartum Issues: The journal also tackles issues that arise after childbirth, focusing on the postpartum period and its implications for maternal health. AJOG MFM serves as a reliable forum for peer-reviewed research, with a preference for randomized trials and meta-analyses. The goal is to equip researchers and clinicians with the most current information and evidence-based strategies to effectively manage high-risk pregnancies and to provide the best possible care for mothers and their unborn children.
期刊最新文献
The Role of Incorporating Maternal-Fetal Medicine Physicians onto Labor and Delivery in Reducing Maternal Morbidity. Intrauterine vacuum and balloon tamponade devices have similar rates of postpartum hemorrhage control: a retrospective cohort study. Intravenous calcium during spinal anesthesia in preeclamptic women receiving magnesium therapy. Is it not Time to Propose a Maternal-Fetal Definition of Fetal Growth Restriction specifically Linked to Maternal Vascular Malperfusion of the Placenta. Letter to The Editor in response to "Oxytocin regimen used for induction of labor and pregnancy outcomes".
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1